Literature DB >> 21118296

Sialidase of Streptococcus intermedius: a putative virulence factor modifying sugar chains.

Ayuko Takao1, Hideaki Nagamune, Nobuko Maeda.   

Abstract

A sialidase gene of Streptococcus intermedius was cloned. It was most similar to nanA, a major sialidase gene in Streptococcus pneumoniae, and was expressed in Escherichia coli. Since the gene-knockout S. intermedius strain lost detectable sialidase activity, the gene might code, either solely or mainly, the glycosidase in the bacterial genome. Polymerase chain reaction using the primers for the nanA homologue in S. intermedius (described as nanA below) showed that this sialidase gene was commonly distributed within the isolates of S. intermedius, but not found in the strains of other species among the anginosus group. In biofilm formation assay under cultivation with mucin, the nanA-deleted S. intermedius maintained the amount of biofilm for 72 hr, while that of the parent strain decreased during incubation from 24 to 72 hr. Since sialidase activity in the parent strain increased during that time period, sialidase might contribute to the degradation of biofilm under sialic acid-rich conditions. When S. intermedius was added into the HepG2 hepatoma culture, the calculated disassociation constant (K(d)) of EDTA-releasable bacterial adhesion to the cells was higher in the nanA-deleted strain than in the parent. Furthermore, the rate constant, assuming endocytosis of the bacterium mediated by ASGP-R in HepG2 cells, seemed to be increased by sialidase pretreatment of the bacterial cells before addition to the cell culture. According to the results, modification of sugar chains by sialidase on the bacterial surface and in the surrounding environment might influence both bacterial interaction and host-bacterial interaction in S. intermedius.
© 2010 The Societies and Blackwell Publishing Asia Pty Ltd.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 21118296     DOI: 10.1111/j.1348-0421.2010.00257.x

Source DB:  PubMed          Journal:  Microbiol Immunol        ISSN: 0385-5600            Impact factor:   1.955


  6 in total

1.  Identification and characterization of a novel secreted glycosidase with multiple glycosidase activities in Streptococcus intermedius.

Authors:  Hidenori Imaki; Toshifumi Tomoyasu; Naoki Yamamoto; Chiharu Taue; Sachiko Masuda; Ayuko Takao; Nobuko Maeda; Atsushi Tabata; Robert A Whiley; Hideaki Nagamune
Journal:  J Bacteriol       Date:  2014-05-23       Impact factor: 3.490

2.  Positive- and Negative-Control Pathways by Blood Components for Intermedilysin Production in Streptococcus intermedius.

Authors:  Toshifumi Tomoyasu; Takahiro Yamasaki; Shinya Chiba; Shingo Kusaka; Atsushi Tabata; Robert A Whiley; Hideaki Nagamune
Journal:  Infect Immun       Date:  2017-08-18       Impact factor: 3.441

3.  Neuraminidase-producing oral mitis group streptococci potentially contribute to influenza viral infection and reduction in antiviral efficacy of zanamivir.

Authors:  Noriaki Kamio; Kenichi Imai; Kazufumi Shimizu; Marni E Cueno; Muneaki Tamura; Yuko Saito; Kuniyasu Ochiai
Journal:  Cell Mol Life Sci       Date:  2014-07-08       Impact factor: 9.261

4.  The impact of the competence quorum sensing system on Streptococcus pneumoniae biofilms varies depending on the experimental model.

Authors:  Claudia Trappetti; Luciana Gualdi; Lorenzo Di Meola; Prashant Jain; Cindy C Korir; Paul Edmonds; Francesco Iannelli; Susanna Ricci; Gianni Pozzi; Marco R Oggioni
Journal:  BMC Microbiol       Date:  2011-04-14       Impact factor: 3.605

Review 5.  From Normal Flora to Brain Abscesses: A Review of Streptococcus intermedius.

Authors:  Elio Issa; Tamara Salloum; Sima Tokajian
Journal:  Front Microbiol       Date:  2020-05-07       Impact factor: 5.640

6.  Phylogenetic relationship and virulence inference of Streptococcus Anginosus Group: curated annotation and whole-genome comparative analysis support distinct species designation.

Authors:  Adam B Olson; Heather Kent; Christopher D Sibley; Margot E Grinwis; Philip Mabon; Claude Ouellette; Shari Tyson; Morag Graham; Shaun D Tyler; Gary Van Domselaar; Michael G Surette; Cindi R Corbett
Journal:  BMC Genomics       Date:  2013-12-17       Impact factor: 3.969

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.